Search

everythinglearnresearchcommunity

for

Search:↓

Environmental pollutants can damage hair health and cause hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Isotretinoin was not effective in treating facial lichen planopilaris.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

New treatments for hair loss may target specific pathways and generate new hair follicles.

The U.S. FDA regulates cosmetics for appearance purposes, but not as strictly as some other countries.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The inhibitor DPP can promote hair growth.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Latanoprost can make eyelashes longer, thicker, and darker.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Finasteride effectively treats male hair loss, increasing length and thickness.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Fullerenes show potential in skin care but need more safety research.

Hair grays due to oxidative stress and fewer functioning melanocytes.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Finasteride and minoxidil work best together for hair loss.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Some nonsurgical hair loss treatments are effective, especially if started early.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.